Show an ad over header. AMP

I am the FIRST!!!

Pfizer raises COVID-19 vaccine sales estimate by 29% to $33.5 billion

Pfizer expects revenue from the COVID-19 vaccine, co-developed by BioNTech, will reach $33.5 billion this year — a 29% jump from the previously estimated $26 billion.

Why it matters: This vaccine, which has dramatically slowed the coronavirus pandemic, is on pace to be the world's top-selling drug of all time, by far. And now Pfizer is pushing for people to get a third "booster" shot of its vaccine to combat the growing Delta variant.


By the numbers: Pfizer registered $7.8 billion of COVID-19 vaccine sales in the second quarter, bringing total worldwide sales so far this year to $11.3 billion.

  • Pfizer expects to deliver 2.1 billion doses this year and has the capacity to manufacture 4 billion doses next year, CEO Albert Bourla said on a conference call.
  • The U.S. previously paid $19.50 per dose for the Pfizer-BioNTech vaccine, but Pfizer recently raised the price to the government to $24 per dose.
  • Flashback: Last year, Bourla said the company would not put a "huge price" on the vaccine, "because that's really taking advantage of a situation, and people will not forget if you do that."

Driving the news: Pfizer said it has new data showing a third dose of its vaccine increases antibody levels significantly against the Delta variant.

  • Pfizer has a financial interest in people, especially Americans, getting a third dose, as it would grow revenues even more.
  • However, epidemiologists have pointed out that higher antibody levels do not mean higher protection, and Pfizer's two-dose schedule is already effective against the coronavirus, including the Delta variant.

The big picture: A majority of the Pfizer-BioNTech vaccine has gone to wealthy countries, whose governments pay higher prices for drugs than lower-income countries.

  • Many lower-income countries have started demanding more doses as their coronavirus cases, hospitalizations and deaths rise.
  • "Africa was largely spared by the pandemic in 2020, but not this year. We lack vaccines, and we are gasping for air," Mosoka Fallah, former director-general of the National Public Health Institute of Liberia, said this week.

What to watch: Moderna reports vaccine sales and earnings Aug. 5.

  • Johnson & Johnson said it expects its COVID-19 vaccine will generate $2.5 billion of sales this year.

regular 4 post ff

infinite scroll 4 pff

Politico staffers mount unionization effort

Members of Politico's newsroom are actively mounting an effort to unionize with the NewsGuild, sources tell Axios.

Why it matters: Politico's newsroom is one of the largest newsrooms to have resisted organizing efforts in the past. A successful unionization drive would be a major win for newsroom labor groups.

Keep reading... Show less

"Whisper campaign": White House mobilizes to defend Harris after flood of leaks

Top White House officials are mobilizing to defend Vice President Kamala Harris amid a gusher of leaks about dysfunction and infighting in her office.

Driving the news: White House Chief of Staff Ron Klain told Axios in a statement: "The President's trust and confidence in her is obvious when you see them in the Oval Office together." Biden senior adviser Cedric Richmond said in an interview late Thursday night: "It’s a whisper campaign designed to sabotage her."

Keep reading... Show less

At least 233 dead in British Columbia amid historic heat wave

More than 230 people have died since Friday as a result of the historic heat wave in British Columbia, Chief Coroner Lisa Lapointe said in a statement Tuesday.

Why it matters: The heatwave in the Pacific Northwest has shattered records and alarmed scientists. In Lytton, British Columbia the temperature soared to 121°F on Tuesday, conditions which, in North America, are usually reserved for the desert Southwest.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
]> &lol4;